Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrmann, D. A.
Right arrow Articles by Imperial, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrmann, D. A.
Right arrow Articles by Imperial, J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 22, Issue 1 141-146, Copyright © 1999 by American Diabetes Association

ARTICLES

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome

DA Ehrmann, RB Barnes, RL Rosenfield, MK Cavaghan and J Imperial
Department of Medicine, University of Chicago, Illinois, USA. dehrmann@medicine.bsd.uchicago.edu

OBJECTIVE: NIDDM occurs commonly among women with polycystic ovary syndrome (PCOS). The prevalence and natural history of its precursor, impaired glucose tolerance (IGT), is less well known. The objective of this study was to characterize the prevalence and incidence of glucose intolerance in a large cohort of women with well-characterized PCOS. RESEARCH DESIGN AND METHODS: A total of 122 women with clinical and hormonal evidence of PCOS were recruited from the Medicine, Endocrinology, Gynecology, and Pediatrics Clinics at the University of Chicago. All women had a standard oral glucose tolerance test (OGTT) with measurement of glucose and insulin levels. A subset of 25 women were subsequently restudied with the aim of characterizing the natural history of glucose tolerance in PCOS. RESULTS: Glucose tolerance was abnormal in 55 (45%) of the 122 women: 43 (35%) had IGT and 12 (10%) had NIDDM at the time of initial study. The women with NIDDM differed from those with normal glucose tolerance in that they had a 2.6-fold higher prevalence of first-degree relatives with NIDDM (83 vs. 31%, P < 0.01 by chi 2) and were significantly more obese (BMI 41.0 +/- 2.4 vs. 33.4 +/- 1.1 kg/m2, P < 0.01). For the entire cohort of 122 women, there was a significant correlation between fasting and 2-h glucose concentrations (r = 0.76, P < 0.0001); among the subset with IGT, the fasting glucose concentration was poorly predictive of the 2-h level (r = 0.25, NS). After a mean follow-up of 2.4 +/- 0.3 years (range 0.5-6.3), 25 women had a second OGTT. The glucose concentration at 2 h during the second glucose tolerance test was significantly higher than the 2-h concentration during the first study (161 +/- 9 vs. 139 +/- 6 mg/dl, P < 0.02). CONCLUSIONS: The prevalence of IGT and NIDDM in women with PCOS is substantially higher than expected when compared with age- and weight-matched populations of women without PCOS. The conversion from IGT to NIDDM is accelerated in PCOS. The fasting glucose concentration does not reliably predict the glucose concentration at 2 h after an oral glucose challenge, particularly among those with IGT, the subgroup at highest risk for subsequent development of NIDDM. We conclude that women with PCOS should periodically have an OGTT and must be closely monitored for deterioration in glucose tolerance.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
A.J. Goverde, A.J.B. van Koert, M.J. Eijkemans, E.A.H. Knauff, H.E. Westerveld, B.C.J.M. Fauser, and F.J. Broekmans
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
Hum. Reprod., December 17, 2008; (2008) den433v1.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel
The Metabolic Syndrome
Endocr. Rev., December 1, 2008; 29(7): 777 - 822.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Tasali, E. Van Cauter, L. Hoffman, and D. A. Ehrmann
Impact of Obstructive Sleep Apnea on Insulin Resistance and Glucose Tolerance in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3878 - 3884.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Vrbikova, M. Hill, B. Bendlova, T. Grimmichova, K. Dvorakova, K. Vondra, and G. Pacini
Incretin levels in polycystic ovary syndrome
Eur. J. Endocrinol., August 1, 2008; 159(2): 121 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Moll, J.C. Korevaar, P.M.M. Bossuyt, and F. van der Veen
Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?
Hum. Reprod., August 1, 2008; 23(8): 1830 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Luque-Ramirez, F. Alvarez-Blasco, M. G. Uriol Rivera, and H. F. Escobar-Morreale
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin
Hum. Reprod., July 1, 2008; 23(7): 1594 - 1601.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
F. Pistrosch, K. Herbrig, S. Parmentier, and P. Gross
New onset of alopecia in a young woman with end-stage renal disease
NDT Plus, June 1, 2008; 1(3): 162 - 163.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
L.P. Cheung, R.C.W. Ma, P.M. Lam, I.H. Lok, C.J. Haines, W.Y. So, P.C.Y. Tong, C.S. Cockram, C.C. Chow, and W.B. Goggins
Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome
Hum. Reprod., June 1, 2008; 23(6): 1431 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S Cupisti, N Kajaia, R Dittrich, H Duezenli, M W Beckmann, and A Mueller
Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome
Eur. J. Endocrinol., May 1, 2008; 158(5): 711 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. E. Recabarren, R. Smith, R. Rios, M. Maliqueo, B. Echiburu, E. Codner, F. Cassorla, P. Rojas, and T. Sir-Petermann
Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1820 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Mohlig, M. O Weickert, E. Ghadamgahi, A. M Arafat, J. Spranger, A. F H Pfeiffer, and C. Schofl
Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
Eur. J. Endocrinol., April 1, 2008; 158(4): 517 - 523.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Zhang, Y.-H. Shi, C.-F. Hao, H. F Gu, Y. Li, Y.-R. Zhao, L.-C. Wang, and Z.-J. Chen
Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women
Eur. J. Endocrinol., February 1, 2008; 158(2): 255 - 260.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. E. Nestler
Metformin for the Treatment of the Polycystic Ovary Syndrome
N. Engl. J. Med., January 3, 2008; 358(1): 47 - 54.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. E. S. Salley, E. P. Wickham, K. I. Cheang, P. A. Essah, N. W. Karjane, and J. E. Nestler
POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome A Position Statement of the Androgen Excess Society
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4546 - 4556.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Sir-Petermann, M. Maliqueo, E. Codner, B. Echiburu, N. Crisosto, V. Perez, F. Perez-Bravo, and F. Cassorla
Early Metabolic Derangements in Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4637 - 4642.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Shroff, A. Kerchner, M. Maifeld, E. J. R. Van Beek, D. Jagasia, and A. Dokras
Young Obese Women with Polycystic Ovary Syndrome Have Evidence of Early Coronary Atherosclerosis
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4609 - 4614.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller
Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome
Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Barbieri
Clomiphene Versus Metformin for Ovulation Induction in Polycystic Ovary Syndrome: The Winner Is ....
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3399 - 3401.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Luque-Ramirez, F. Alvarez-Blasco, J. I. Botella-Carretero, R. Sanchon, J. L. San Millan, and H. F. Escobar-Morreale
Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses
Diabetes Care, September 1, 2007; 30(9): 2309 - 2313.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Hahn, M. Backhaus, M. Broecker-Preuss, S. Tan, T. Dietz, R. Kimmig, M. Schmidt, K. Mann, and O. E Janssen
Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism
Eur. J. Endocrinol., August 1, 2007; 157(2): 201 - 207.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Luque-Ramirez, F. Alvarez-Blasco, J. I. Botella-Carretero, E. Martinez-Bermejo, M. A. Lasuncion, and H. F. Escobar-Morreale
Comparison of Ethinyl-Estradiol Plus Cyproterone Acetate Versus Metformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2453 - 2461.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Crisosto, E. Codner, M. Maliqueo, B. Echiburu, F. Sanchez, F. Cassorla, and T. Sir-Petermann
Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2739 - 2743.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo
Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome
Hum. Reprod., July 1, 2007; 22(7): 1830 - 1836.
[Abstract] [Full Text] [PDF]

Home page
 cfpHome page
S. D. Pedersen, S. Brar, P. Faris, and B. Corenblum
Polycystic ovary syndrome: Validated questionnaire for use in diagnosis
Can Fam Physician, June 1, 2007; 53(6): 1041 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Luque-Ramirez, F. Alvarez-Blasco, C. Mendieta-Azcona, J. I. Botella-Carretero, and H. F. Escobar-Morreale
Obesity Is the Major Determinant of the Abnormalities in Blood Pressure Found in Young Women with the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2141 - 2148.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, Y.-P. Hsu, J.-L. Hwang, L.-W. Huang, and L.-T. Ho
Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery
Hum. Reprod., April 1, 2007; 22(4): 1003 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
C. Gagnon and J.-P. Baillargeon
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome
Can. Med. Assoc. J., March 27, 2007; 176(7): 933 - 938.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. S. Legro
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
JAMA, February 7, 2007; 297(5): 509 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Belosi, L. Selvaggi, R. Apa, M. Guido, D. Romualdi, A.M. Fulghesu, and A. Lanzone
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?
Hum. Reprod., December 1, 2006; 21(12): 3108 - 3115.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H. F. Escobar-Morreale, W. Futterweit, O. E. Janssen, R. S. Legro, R. J. Norman, A. E. Taylor, et al.
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4237 - 4245.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
F. Alvarez-Blasco, J. I. Botella-Carretero, J. L. San Millan, and H. F. Escobar-Morreale
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
Arch Intern Med, October 23, 2006; 166(19): 2081 - 2086.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Eur. J. Endocrinol., August 1, 2006; 155(2): 337 - 345.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
X. Chen, D. Yang, L. Li, S. Feng, and L. Wang
Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome
Hum. Reprod., August 1, 2006; 21(8): 2027 - 2032.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S.K. Blank, C.R. McCartney, and J.C. Marshall
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. Pasquali and A. Gambineri
Insulin-sensitizing agents in polycystic ovary syndrome.
Eur. J. Endocrinol., June 1, 2006; 154(6): 763 - 775.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Diamanti-Kandarakis, T. Paterakis, K. Alexandraki, C. Piperi, A. Aessopos, I. Katsikis, N. Katsilambros, G. Kreatsas, and D. Panidis
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Hum. Reprod., June 1, 2006; 21(6): 1426 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Sam, R. S. Legro, P. A. Essah, T. Apridonidze, and A. Dunaif
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome
PNAS, May 2, 2006; 103(18): 7030 - 7035.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. L. Setji, N. D. Holland, L. L. Sanders, K. C. Pereira, A. M. Diehl, and A. J. Brown
Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1741 - 1747.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. I. Leibel, E. E. Baumann, M. Kocherginsky, and R. L. Rosenfield
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1275 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. L. Ding, Y. Song, V. S. Malik, and S. Liu
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
JAMA, March 15, 2006; 295(11): 1288 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 781 - 785.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Corbould, H. Zhao, S. Mirzoeva, F. Aird, and A. Dunaif
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Diabetes, March 1, 2006; 55(3): 751 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
T. Bridger, S. MacDonald, F. Baltzer, and C. Rodd
Randomized Placebo-Controlled Trial of Metformin for Adolescents With Polycystic Ovary Syndrome
Arch Pediatr Adolesc Med, March 1, 2006; 160(3): 241 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. C Deedwania and R. Schmieder
Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1_suppl): S12 - S18.
[Abstract] [PDF]

Home page
 Eur J EndocrinolHome page
M. Mohlig, J. Spranger, M. Ristow, A. F H Pfeiffer, T. Schill, H. W Schlosser, L. Moltz, G. Brabant, and C. Schofl
Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome
Eur. J. Endocrinol., February 1, 2006; 154(2): 295 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
C. C.W. Chan, M. W.L. Koo, E. H.Y. Ng, O.-S. Tang, W. S.B. Yeung, and P.-C. Ho
Effects of Chinese Green Tea on Weight, and Hormonal and Biochemical Profiles in Obese Patients With Polycystic Ovary Syndrome--A Randomized Placebo-Controlled Trial
Reproductive Sciences, January 1, 2006; 13(1): 63 - 68.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Tasali, E. Van Cauter, and D. A. Ehrmann
Relationships between Sleep Disordered Breathing and Glucose Metabolism in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. A. Ehrmann, D. R. Liljenquist, K. Kasza, R. Azziz, R. S. Legro, M. N. Ghazzi, and for the PCOS/Troglitazone Study Group
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 48 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. A. Cataldo, F. Abbasi, T. L. McLaughlin, M. Basina, P. Y. Fechner, L. C. Giudice, and G. M. Reaven
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
Hum. Reprod., January 1, 2006; 21(1): 109 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Yilmaz, N. Bukan, G. Ayvaz, A. Karakoc, F. Toruner, N. Cakir, and M. Arslan
The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome
Hum. Reprod., December 1, 2005; 20(12): 3333 - 3340.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Vrbikova, K. Vondra, D. Cibula, K. Dvorakova, S. Stanicka, D. Sramkova, G. Sindelka, M. Hill, B. Bendlova, and J. Skrha
Metabolic syndrome in young Czech women with polycystic ovary syndrome
Hum. Reprod., December 1, 2005; 20(12): 3328 - 3332.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. Diamanti-Kandarakis and C. Piperi
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Hum. Reprod. Update, November 1, 2005; 11(6): 631 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
G. Villuendas, J. I. Botella-Carretero, B. Roldan, J. Sancho, H. F. Escobar-Morreale, and J. L. S. Millan
Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls
Hum. Reprod., November 1, 2005; 20(11): 3184 - 3191.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Johnsen, S. E. Dolan, K. V. Fitch, K. M. Killilea, J. L. Shifren, and S. K. Grinspoon
Absence of Polycystic Ovary Syndrome Features in Human Immunodeficiency Virus-Infected Women Despite Significant Hyperinsulinemia and Truncal Adiposity
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5596 - 5604.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Yilmaz, N. Bukan, R. Ersoy, A. Karakoc, I. Yetkin, G. Ayvaz, N. Cakir, and M. Arslan
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome
Hum. Reprod., September 1, 2005; 20(9): 2414 - 2420.
[Abstract] [Full Text] [PDF]

Home page